Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro - PubMed (original) (raw)

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

W E Carson et al. J Clin Invest. 1995 Dec.

Abstract

Natural killer (NK) cells are large granular lymphocytes that constitutively express functional IL-2 receptors. We have shown that recombinant human IL-15 uses the IL-2 receptor to activate human NK cells and can synergize with recombinant human IL-12 to stimulate NK cell production of IFN-gamma in vitro. IFN-gamma production by NK cells is critical in the prevention of overwhelming infection by obligate intracellular microbial pathogens in several experimental animal models. Herein, we demonstrate that human monocytes produce IL-15 protein within 5 h of activation with LPS. Using an IL-15-neutralizing antiserum in a coculture of LPS-activated monocytes and NK cells, we demonstrate that monocyte-derived IL-15 is critical for optimal NK cell production of IFN-gamma. Endogenous IL-15 activates NK cells through the IL-2 receptor, and with endogenous IL-12, regulates NK cell IFN-gamma after monocyte activation by LPS. These in vitro studies are the first to characterize a function for endogenous IL-15, and as such, suggest an important role for IL-15 during the innate immune response. IL-15 may be an important ligand for the NK cell IL-2 receptor in vivo.

PubMed Disclaimer

Similar articles

• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
  Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA. Fehniger TA, et al. J Immunol. 1999 Apr 15;162(8):4511-20. J Immunol. 1999. PMID: 10201989
• TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
  Berger M, Ablasser A, Kim S, Bekeredjian-Ding I, Giese T, Endres S, Hornung V, Hartmann G. Berger M, et al. J Immunother. 2009 Apr;32(3):262-71. doi: 10.1097/CJI.0b013e318198bd2a. J Immunother. 2009. PMID: 19242374
• Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response.
  Nomura A, Takada H, Jin CH, Tanaka T, Ohga S, Hara T. Nomura A, et al. Exp Hematol. 2001 Oct;29(10):1169-76. doi: 10.1016/s0301-472x(01)00689-0. Exp Hematol. 2001. PMID: 11602318 Review.
• Interleukin-15 as a potential regulator of the innate immune response.
  Carson W, Caligiuri MA. Carson W, et al. Braz J Med Biol Res. 1998 Jan;31(1):1-9. doi: 10.1590/s0100-879x1998000100001. Braz J Med Biol Res. 1998. PMID: 9686173 Review.

Cited by

• Swollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome.
  Kovalik ME, Dacanay MA, Crowley SD, Hall G. Kovalik ME, et al. Biomedicines. 2024 Mar 26;12(4):738. doi: 10.3390/biomedicines12040738. Biomedicines. 2024. PMID: 38672094 Free PMC article. Review.
• Interleukin-15 in kidney disease and therapeutics.
  Hall G. Hall G. Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):174-180. doi: 10.1097/MNH.0000000000000964. Epub 2023 Dec 26. Curr Opin Nephrol Hypertens. 2024. PMID: 38164877 Review.
• Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies.
  Lui G, Minnar CM, Soon-Shiong P, Schlom J, Gameiro SR. Lui G, et al. Cells. 2023 Jun 12;12(12):1611. doi: 10.3390/cells12121611. Cells. 2023. PMID: 37371081 Free PMC article. Review.
• The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy.
  Yu Y. Yu Y. Cancers (Basel). 2023 Apr 16;15(8):2323. doi: 10.3390/cancers15082323. Cancers (Basel). 2023. PMID: 37190251 Free PMC article. Review.
• IFN-γ and TGF-β, Crucial Players in Immune Responses: A Tribute to Howard Young.
  Gauthier T, Chen W. Gauthier T, et al. J Interferon Cytokine Res. 2022 Dec;42(12):643-654. doi: 10.1089/jir.2022.0132. J Interferon Cytokine Res. 2022. PMID: 36516375 Free PMC article. Review.

References

1. 1. J Immunol. 1978 Jun;120(6):2027-32 - PubMed
2. 1. Blood. 1995 Feb 15;85(4):1063-74 - PubMed
3. 1. J Immunol. 1989 Feb 1;142(3):800-7 - PubMed
4. 1. J Exp Med. 1989 Jul 1;170(1):291-6 - PubMed
5. 1. Adv Immunol. 1989;47:187-376 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations